CClinicalTrials.gg
Active, not recruitingNCT07211971Updated Oct 8, 2025

the Value of Flexible Bronchoscopy in the Neonatal Intensive Care Unit at Sohag University Hospitals

An interventional study of retrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025. in Study Including Neonates Who Underwent Flexible Fiberoptic Bronchoscopy in Last 10 Years at Sohag University Hospitals, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 1 Day to 28 Days. Per ClinicalTrials.gov, last updated 2025-10-08.

Sponsored by Sohag University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
1 Day to 28 Days
Sex
All
01

Study summary

The aim of this study to describe the utility of flexible fiberoptic bronchoscopy for the diagnosis and management of different respiratory diseases in the neonatal ICU.

Read the detailed description

Study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025. The study population comprised neonates admitted to the NICU in Sohag University Hospitals between January 2015 and january 2025.

  • The inclusion criteria were neonates aged from 1 day to 28 days with recurrent dyspnea, stridor, recurrent chocking or suspicious respiratory tract anomaly; with recurrent pulmonary infection or atelectasis in the same lung lobe; with suspicious tracheal stenosis in radiological image [X-ray or computed tomography (CT) scan]; inability to be extubated without clear reason; or confirmed congenital esophageal atresia to clarify the presence and position of esophagobronchial fistula before surgery.
  • Exclusion criteria : neonates with neurological , cardiac problem ,age above 28 days Clinical data such as age, sex; weight at bronchoscopy; mechanical ventilation during hospitalization.
  • Clinical indications and results of bronchoscopy were also retrospectively collected.
  • Medical and surgical intervention needed for management after diagnosis by FB.
02

Conditions studied

  • Study Including Neonates Who Underwent Flexible Fiberoptic Bronchoscopy in Last 10 Years at Sohag University Hospitals
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • neonates aged from 1 day to 28 days with recurrent dyspnea, stridor, recurrent chocking or suspicious respiratory tract anomaly; with recurrent pulmonary infection or atelectasis in the same lung lobe; with suspicious tracheal stenosis in radiological image [X-ray or computed tomography (CT) scan]; inability to be extubated without clear reason; or confirmed congenital esophageal atresia to clarify the presence and position of esophagobronchial fistula before surgery.

Exclusion criteria

Exclusion Criteria:

neonates with neurological , cardiac problem ,age above 28 days

-

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    neonates who underwent flexible fiberoptic bronchoscopy

    Diagnostic Test: retrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025.

Interventions

  • Diagnostic testretrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025.

    retrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025.

06

What researchers measure

Primary outcomes

  1. the number of patients underwent flexible bronchoscopy in NICU at sohag university hospitals

    this study conducted to detrmine the number of patient underwent flexible bronchoscopy and importance of flexible bronchoscopy to reach final diagnosis and help in management of different respiratory diseases in NICU at sohag university hospitals by using the documented data including (number of patients, result of bronchoscopy of each patient as diagnosis and treatment)

    Time frame: immediatly after bronchoscopy

  2. diagnosis of each neonate which reached by the broncscopy

    this study conducted to detrmine the number of patient underwent flexible bronchoscopy and importance of flexible bronchoscopy to reach final diagnosis and help in management of different respiratory diseases in NICU at sohag university hospitals by using the documented data including (number of patients, result of bronchoscopy of each patient as diagnosis and treatment)

    Time frame: immediatly after bronchoscopy

07

Study locations

1 site
  • Faculty of Medicine Sohag University
    Sohag, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07211971
Lead sponsor
Sohag University
Responsible party
Hager Khaled Abdelmonem (Resident physician in the Department of Pediatrics and Neonatology, Sohag University) — Principal investigator
First posted
Oct 8, 2025
Start date
Sep 10, 2025
Primary completion
Sep 10, 2026 (estimated)
Completion
Sep 10, 2026 (estimated)
Last update
Oct 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion